תוצאות חיפוש - Sybille Landwehr-Kenzel
- Showing 1 - 5 results of 5
-
1
-
2
Novel GMP-Compatible Protocol Employing an Allogeneic B Cell Bank for Clonal Expansion of Allospecific Natural Regulatory T Cells מאת Sybille Landwehr-Kenzel, Fadi Issa, Si-Hong Luu, Michael Schmück, Hong Lei, Anne Zobel, Andreas Thiel, Nina Babel, K Wood, Hans‐Dieter Volk, Petra Reinke
יצא לאור 2014Artigo -
3
Supraphysiological FOXP3 expression in human CAR-Tregs results in improved stability, efficacy, and safety of CAR-Treg products for clinical application מאת Pierre Henschel, Sybille Landwehr-Kenzel, Niklas Engels, Andrea Schienke, Jakob Kremer, Tobias Riët, Nella Redel, Konstantinos Iordanidis, Valerie Saetzler, Katharina John, Miriam Heider, Matthias Hardtke‐Wolenski, Heiner Wedemeyer, Elmar Jaeckel, Fatih Noyan
יצא לאור 2023Artigo -
4
Adoptive transfer of ex vivo expanded regulatory T cells improves immune cell engraftment and therapy-refractory chronic GvHD מאת Sybille Landwehr-Kenzel, Leonie Müller‐Jensen, Joern-Sven Kuehl, Mohamed Abou‐El‐Enein, Henrike Hoffmann, Sandra Muench, Daniel R. Kaiser, Andy Roemhild, Horst von Bernuth, Mirjam Voeller, Michael Schmueck‐Henneresse, Bernd Gruhn, Ulrik Stervbo, Nina Babel, Hans‐Dieter Volk, Petra Reinke
יצא לאור 2022Artigo -
5
Regulatory T cells for minimising immune suppression in kidney transplantation: phase I/IIa clinical trial מאת Andy Roemhild, Natalie Otto, Guido Moll, Mohamed Abou‐El‐Enein, Daniel R. Kaiser, Gantuja Bold, Thomas Schachtner, Mira Choi, Robert Oellinger, Sybille Landwehr-Kenzel, Karsten Juerchott, Birgit Sawitzki, Cordula Giesler, Anett Sefrin, Carola Beier, Dimitrios L. Wagner, Stephan Schlickeiser, Mathias Streitz, Michael Schmueck‐Henneresse, Leila Amini, Ulrik Stervbo, Nina Babel, Hans‐Dieter Volk, Petra Reinke
יצא לאור 2020Artigo
כלי חיפוש:
נושאים קשורים
Immune system
Immunology
Biology
Medicine
T cell
Transplantation
Adoptive cell transfer
Autoimmunity
FOXP3
Genetics
Immunosuppression
Internal medicine
Surgery
Adverse effect
Antigen
Bacteria
Bacterial adhesin
Biotechnology
Cancer research
Cell therapy
Clinical endpoint
Clinical trial
Computational biology
Daclizumab
Effector
Everolimus
Ex vivo
Fulminant
Gene
Graft-versus-host disease